Related Experiment Videos
Is the ApoE polymorphism associated with dilated cardiomyopathy?
D Jurkovicova1, E Goncalvesova, B Sedlakova
1Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Slovakia. dana.jurkovicova@savba.sk
General Physiology and Biophysics
|May 23, 2006
Summary
The ApoE epsilon4 allele, linked to cardiovascular risks, is significantly more frequent in dilated cardiomyopathy patients. This suggests a potential association between Apolipoprotein E gene variations and severe heart failure.
Area of Science:
- Genetics
- Cardiology
- Biochemistry
Background:
- Apolipoprotein E (ApoE) is crucial for cholesterol transport and homeostasis.
- ApoE gene polymorphism is linked to cardiovascular and neuronal diseases.
- The ApoE epsilon4 allele is a known risk factor for cardiovascular diseases.
Purpose of the Study:
- To investigate the frequency of ApoE gene polymorphism in patients with end-stage dilated cardiomyopathy (DCM).
- To correlate ApoE genotypes with clinical parameters in DCM patients.
Main Methods:
- Utilized a novel PCR and blotting technique (CVD StripAssay) for rapid ApoE gene polymorphism screening.
- Examined 50 patients with end-stage DCM and advanced congestive heart failure.
- Correlated individual genotypes with basic cardiologic clinical parameters.
Main Results:
- The frequency of the ApoE epsilon4 allele was 40% in DCM patients, significantly higher than the 14.7% in the general Caucasian population.
- Genotype frequencies in DCM patients were epsilon2/4 (58%) and epsilon3/4 (22%).
- A significantly increased frequency of the epsilon4 allele was observed in advanced DCM stages compared to control groups.
Conclusions:
- Apolipoprotein E polymorphism is associated with severe forms of dilated cardiomyopathy.
- The increased prevalence of the ApoE epsilon4 allele in DCM warrants further investigation into its physiological consequences.